In 2022, the global biopharmaceutical CMO and CRO market was estimated to be worth USD 28.70 billion. By 2030, it is expected to have grown to USD 51.36 billion, with a CAGR of 6.68% from 2022 to 2030. North America maintained the greatest revenue share in 2021, accounting for nearly 35% of overall sales.
Size of the Biopharmaceutical CMO and CRO Market
In 20212, the global biopharmaceutical cmo market was estimated to be worth USD 28.70 billion. By 2030, it is expected to have grown to USD 51.36 billion, with a CAGR of 6.68% from 2022 to 2030. North America maintained the greatest revenue share in 2021, accounting for nearly 35% of overall sales.
Facebook Conversations